Logo image of CE

CELANESE CORP (CE) Stock Fundamental Analysis

USA - NYSE:CE - US1508701034 - Common Stock

39.12 USD
-2.28 (-5.51%)
Last: 11/12/2025, 8:04:00 PM
39.12 USD
0 (0%)
After Hours: 11/12/2025, 8:04:00 PM
Fundamental Rating

4

Overall CE gets a fundamental rating of 4 out of 10. We evaluated CE against 82 industry peers in the Chemicals industry. CE may be in some trouble as it scores bad on both profitability and health. CE is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CE was profitable.
In the past year CE had a positive cash flow from operations.
Of the past 5 years CE 4 years were profitable.
Each year in the past 5 years CE had a positive operating cash flow.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

CE's Return On Assets of -6.83% is on the low side compared to the rest of the industry. CE is outperformed by 76.83% of its industry peers.
The Return On Equity of CE (-30.71%) is worse than 76.83% of its industry peers.
CE has a Return On Invested Capital of 3.49%. This is comparable to the rest of the industry: CE outperforms 47.56% of its industry peers.
CE had an Average Return On Invested Capital over the past 3 years of 4.41%. This is in line with the industry average of 6.13%.
Industry RankSector Rank
ROA -6.83%
ROE -30.71%
ROIC 3.49%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CE's Operating Margin of 9.38% is in line compared to the rest of the industry. CE outperforms 54.88% of its industry peers.
CE's Operating Margin has declined in the last couple of years.
CE has a Gross Margin (21.85%) which is comparable to the rest of the industry.
CE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.38%
PM (TTM) N/A
GM 21.85%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CE is destroying value.
Compared to 1 year ago, CE has more shares outstanding
CE has less shares outstanding than it did 5 years ago.
CE has a worse debt/assets ratio than last year.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.50, we must say that CE is in the distress zone and has some risk of bankruptcy.
CE's Altman-Z score of 1.50 is on the low side compared to the rest of the industry. CE is outperformed by 64.63% of its industry peers.
CE has a debt to FCF ratio of 20.48. This is a negative value and a sign of low solvency as CE would need 20.48 years to pay back of all of its debts.
CE has a Debt to FCF ratio (20.48) which is in line with its industry peers.
CE has a Debt/Equity ratio of 2.43. This is a high value indicating a heavy dependency on external financing.
CE's Debt to Equity ratio of 2.43 is on the low side compared to the rest of the industry. CE is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 20.48
Altman-Z 1.5
ROIC/WACC0.5
WACC7.05%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CE has a Current Ratio of 2.05. This indicates that CE is financially healthy and has no problem in meeting its short term obligations.
CE has a Current ratio (2.05) which is in line with its industry peers.
A Quick Ratio of 1.22 indicates that CE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.22, CE is in line with its industry, outperforming 43.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.22
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

CE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.48%.
The Earnings Per Share has been decreasing by -2.59% on average over the past years.
CE shows a decrease in Revenue. In the last year, the revenue decreased by -6.03%.
The Revenue has been growing by 10.30% on average over the past years. This is quite good.
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%

3.2 Future

CE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.09% yearly.
The Revenue is expected to grow by 0.51% on average over the next years.
EPS Next Y-47.45%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
EPS Next 5Y5.09%
Revenue Next Year-5.37%
Revenue Next 2Y-1.66%
Revenue Next 3Y0.05%
Revenue Next 5Y0.51%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

CE is valuated reasonably with a Price/Earnings ratio of 8.15.
Compared to the rest of the industry, the Price/Earnings ratio of CE indicates a rather cheap valuation: CE is cheaper than 90.24% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.34, CE is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.60, the valuation of CE can be described as very cheap.
Based on the Price/Forward Earnings ratio, CE is valued cheaply inside the industry as 91.46% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.43. CE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.15
Fwd PE 6.6
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CE is cheaper than 62.20% of the companies in the same industry.
CE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CE is cheaper than 93.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.78
EV/EBITDA 9.28
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

CE's earnings are expected to decrease with -2.68% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.31%, CE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.95, CE is paying slightly less dividend.
With a Dividend Yield of 0.31, CE pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

The dividend of CE has a limited annual growth rate of 3.06%.
CE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CE decreased recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of CE are negative and hence is the payout ratio. CE will probably not be able to sustain this dividend level.
CE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-9.81%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

CELANESE CORP

NYSE:CE (11/12/2025, 8:04:00 PM)

After market: 39.12 0 (0%)

39.12

-2.28 (-5.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners107.4%
Inst Owner Change-0.47%
Ins Owners0.27%
Ins Owner Change0.31%
Market Cap4.28B
Revenue(TTM)10.28B
Net Income(TTM)-1.62B
Analysts72
Price Target55.94 (43%)
Short Float %7.64%
Short Ratio4.58
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-9.81%
Div Incr Years0
Div Non Decr Years1
Ex-Date10-28 2025-10-28 (0.03)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.13%
Min EPS beat(2)-0.14%
Max EPS beat(2)44.41%
EPS beat(4)2
Avg EPS beat(4)11.14%
Min EPS beat(4)-16.92%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.27%
EPS beat(12)5
Avg EPS beat(12)1.38%
EPS beat(16)7
Avg EPS beat(16)2.17%
Revenue beat(2)1
Avg Revenue beat(2)0.76%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)2.89%
Revenue beat(4)1
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.21%
Revenue beat(12)1
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-2.02%
PT rev (1m)0.5%
PT rev (3m)-14.15%
EPS NQ rev (1m)-1.31%
EPS NQ rev (3m)-29.66%
EPS NY rev (1m)-2.3%
EPS NY rev (3m)-16.56%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 8.15
Fwd PE 6.6
P/S 0.43
P/FCF 6.78
P/OCF 4.2
P/B 0.81
P/tB N/A
EV/EBITDA 9.28
EPS(TTM)4.8
EY12.27%
EPS(NY)5.92
Fwd EY15.14%
FCF(TTM)5.77
FCFY14.75%
OCF(TTM)9.32
OCFY23.81%
SpS90.77
BVpS48.18
TBVpS-36.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number72.14
Profitability
Industry RankSector Rank
ROA -6.83%
ROE -30.71%
ROCE 4.45%
ROIC 3.49%
ROICexc 3.7%
ROICexgc 6.89%
OM 9.38%
PM (TTM) N/A
GM 21.85%
FCFM 6.36%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexgc growth 3Y-25.53%
ROICexgc growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 20.48
Debt/EBITDA 7.49
Cap/Depr 49.62%
Cap/Sales 3.9%
Interest Coverage 250
Cash Conversion 59.51%
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.22
Altman-Z 1.5
F-Score4
WACC7.05%
ROIC/WACC0.5
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
EPS Next Y-47.45%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
EPS Next 5Y5.09%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%
Revenue Next Year-5.37%
Revenue Next 2Y-1.66%
Revenue Next 3Y0.05%
Revenue Next 5Y0.51%
EBIT growth 1Y-19.24%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year22.28%
EBIT Next 3Y12.65%
EBIT Next 5Y9.93%
FCF growth 1Y-41.64%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-39.07%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%

CELANESE CORP / CE FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CE.


What is the valuation status for CE stock?

ChartMill assigns a valuation rating of 7 / 10 to CELANESE CORP (CE). This can be considered as Undervalued.


What is the profitability of CE stock?

CELANESE CORP (CE) has a profitability rating of 3 / 10.


Can you provide the financial health for CE stock?

The financial health rating of CELANESE CORP (CE) is 3 / 10.


What is the expected EPS growth for CELANESE CORP (CE) stock?

The Earnings per Share (EPS) of CELANESE CORP (CE) is expected to decline by -47.45% in the next year.